4.6 Article

Substrate-Based Design of Cytosolic Nucleotidase IIIB Inhibitors and Structural Insights into Inhibition Mechanism

Journal

PHARMACEUTICALS
Volume 15, Issue 5, Pages -

Publisher

MDPI
DOI: 10.3390/ph15050554

Keywords

nucleotidase; cN-IIIB; NT5C3B; nucleotide-based inhibitor; 7-methylguanosine

Funding

  1. National Science Centre in Poland [UMO-2017/24/C/NZ1/00169, UMO-2018/31/B/ST5/03821, UMO-2016/21/D/NZ1/02806, UMO-2019/32/T/ST4/00073]
  2. Foundation for Polish Science [TEAM/20162/13]
  3. Faculty of Physics, University ofWarsaw [(PP/BF) 501-D111-01-1110102]
  4. [POIG.02.01.00-14-122/09]

Ask authors/readers for more resources

This study aimed to develop molecular tools for advanced studies on the cellular role of cytosolic nucleotidase cN-IIIB. Through substrate and inhibitor property profiling of a library of 41 substrate analogs, several 7-benzylguanosine 5'-monophosphate derivatives were identified as potent, unhydrolyzable inhibitors of cN-IIIB. The inhibitory mechanism was elucidated using X-ray crystallography and molecular docking, and it was demonstrated that these compounds can inhibit m(7)GMP decay in cell lysates.
Cytosolic nucleotidases (cNs) catalyze dephosphorylation of nucleoside 5'-monophosphates and thereby contribute to the regulation of nucleotide levels in cells. cNs have also been shown to dephosphorylate several therapeutically relevant nucleotide analogues. cN-IIIB has shown in vitro a distinctive activity towards 7-mehtylguanosine monophosphate (m(7)GMP), which is one key metabolites of mRNA cap. Consequently, it has been proposed that cN-IIIB participates in mRNA cap turnover and prevents undesired accumulation and salvage of m(7)GMP. Here, we sought to develop molecular tools enabling more advanced studies on the cellular role of cN-IIIB. To that end, we performed substrate and inhibitor property profiling using a library of 41 substrate analogs. The most potent hit compounds (identified among m(7)GMP analogs) were used as a starting point for structure- activity relationship studies. As a result, we identified several 7-benzylguanosine 5'-monophosphate (Bn(7)GMP) derivatives as potent, unhydrolyzable cN-IIIB inhibitors. The mechanism of inhibition was elucidated using X-ray crystallography and molecular docking. Finally, we showed that compounds that potently inhibit recombinant cN-IIIB have the ability to inhibit m(7)GMP decay in cell lysates.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available